Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Don’t Discount The AI Potential Of Ambarella; Buy On The Dip By: MarketBeat May 31, 2023 at 08:35 AM EDT Some high expectations were built into the Ambarella (NASDAQ: AMBA) market, driven by NVIDIA’s (NASDAQ: NVDA) blow-out report and the outlook for AI. Ambarella’s CV3 (3rd gen computer vision) system-on-a-chip family puts the company in a prime position for the AI boom. The caveat is that Ambarella’s AI technology is focused on computer vision for IoT and EV applications, and that isn’t where investor attention is focused now. Investor Attention is focused on generative AI/data center names like NVIDIA, Advanced Micro Devices (NASDAQ: AMD), and Marvell (NASDAQ: MRVL) because they represent the first wave in the build-up of the AI age. The takeaway is that Ambarella’s Q1 report and guidance did not reflect the AI boom as expected, but they will. “We are pleased to announce our first CV3 platform win through our partnership with Continental … in a L4 commercial vehicle application,” said Fermi Wang, President and CEO. “... we are taking our inference AI strategy to the next level with our R&D investment focused on the build-out of our CV3 platform as well as new derivatives of our 3rd generation AI technology.” Ambarella Has a Solid Quarter, Guided Weak Ambarella had a decent quarter but did not provide the market with a catalyst to justify the 15% run-up in share prices before the release. The company reported $62.14 million in revenue, which beat the consensus but only by 20 basis points and is down 31.2% compared to last year. The decline is due to cyclical headwinds that have reduced or pushed off demand in end markets, and there is no indication of a pick-up anytime soon. The company’s margin contracted compared to last year, but the details are not all bad. The gross margin declined by 70 basis points, and the operating loss widened, but GAAP and adjusted earnings were better than expected. An increase in R&D spending was offset by a decline in SG&A that left the adjusted EPS at -$0.15 compared to the -$0.21 forecast by the Marketbeat.com consensus figure. The bad news is that Q1's relative strength did not lead to positive guidance. The company expects revenue to run flattish compared to Q1 versus the consensus figure, which expected about 10% sequential growth, and the whisper figures suggested an NVIDIA-like blowout was possible. The Analysts Will Cap Price Action In 2023 The analysts rate Ambarella a Moderate Buy, but their activity will cap gains in 2023. The consensus price target is about 25% above the post-release price action but has been trending lower all year. The downtrend in the consensus target is not likely to end with the new guidance, but there is some good news too. The downtrend in the consensus target is due primarily to the top end of the range coming down; the most recent targets are reduced but to levels above the consensus. In this light, the analysts will likely cap gains in 2023 but will also support the market within its current trading range. The chart of Ambarella price action is worrisome. The pre and post-release action have the market set up to form an Abandoned Baby, a potentially bearish scenario. The Abandoned Baby may precede a downtrend but, in this case, represents a critical point of resistance. If the market can not move above the $80 level soon, the odds of range-bound trading in the 2nd half of the year will grow. Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Don’t Discount The AI Potential Of Ambarella; Buy On The Dip By: MarketBeat May 31, 2023 at 08:35 AM EDT Some high expectations were built into the Ambarella (NASDAQ: AMBA) market, driven by NVIDIA’s (NASDAQ: NVDA) blow-out report and the outlook for AI. Ambarella’s CV3 (3rd gen computer vision) system-on-a-chip family puts the company in a prime position for the AI boom. The caveat is that Ambarella’s AI technology is focused on computer vision for IoT and EV applications, and that isn’t where investor attention is focused now. Investor Attention is focused on generative AI/data center names like NVIDIA, Advanced Micro Devices (NASDAQ: AMD), and Marvell (NASDAQ: MRVL) because they represent the first wave in the build-up of the AI age. The takeaway is that Ambarella’s Q1 report and guidance did not reflect the AI boom as expected, but they will. “We are pleased to announce our first CV3 platform win through our partnership with Continental … in a L4 commercial vehicle application,” said Fermi Wang, President and CEO. “... we are taking our inference AI strategy to the next level with our R&D investment focused on the build-out of our CV3 platform as well as new derivatives of our 3rd generation AI technology.” Ambarella Has a Solid Quarter, Guided Weak Ambarella had a decent quarter but did not provide the market with a catalyst to justify the 15% run-up in share prices before the release. The company reported $62.14 million in revenue, which beat the consensus but only by 20 basis points and is down 31.2% compared to last year. The decline is due to cyclical headwinds that have reduced or pushed off demand in end markets, and there is no indication of a pick-up anytime soon. The company’s margin contracted compared to last year, but the details are not all bad. The gross margin declined by 70 basis points, and the operating loss widened, but GAAP and adjusted earnings were better than expected. An increase in R&D spending was offset by a decline in SG&A that left the adjusted EPS at -$0.15 compared to the -$0.21 forecast by the Marketbeat.com consensus figure. The bad news is that Q1's relative strength did not lead to positive guidance. The company expects revenue to run flattish compared to Q1 versus the consensus figure, which expected about 10% sequential growth, and the whisper figures suggested an NVIDIA-like blowout was possible. The Analysts Will Cap Price Action In 2023 The analysts rate Ambarella a Moderate Buy, but their activity will cap gains in 2023. The consensus price target is about 25% above the post-release price action but has been trending lower all year. The downtrend in the consensus target is not likely to end with the new guidance, but there is some good news too. The downtrend in the consensus target is due primarily to the top end of the range coming down; the most recent targets are reduced but to levels above the consensus. In this light, the analysts will likely cap gains in 2023 but will also support the market within its current trading range. The chart of Ambarella price action is worrisome. The pre and post-release action have the market set up to form an Abandoned Baby, a potentially bearish scenario. The Abandoned Baby may precede a downtrend but, in this case, represents a critical point of resistance. If the market can not move above the $80 level soon, the odds of range-bound trading in the 2nd half of the year will grow.
Some high expectations were built into the Ambarella (NASDAQ: AMBA) market, driven by NVIDIA’s (NASDAQ: NVDA) blow-out report and the outlook for AI. Ambarella’s CV3 (3rd gen computer vision) system-on-a-chip family puts the company in a prime position for the AI boom. The caveat is that Ambarella’s AI technology is focused on computer vision for IoT and EV applications, and that isn’t where investor attention is focused now. Investor Attention is focused on generative AI/data center names like NVIDIA, Advanced Micro Devices (NASDAQ: AMD), and Marvell (NASDAQ: MRVL) because they represent the first wave in the build-up of the AI age. The takeaway is that Ambarella’s Q1 report and guidance did not reflect the AI boom as expected, but they will. “We are pleased to announce our first CV3 platform win through our partnership with Continental … in a L4 commercial vehicle application,” said Fermi Wang, President and CEO. “... we are taking our inference AI strategy to the next level with our R&D investment focused on the build-out of our CV3 platform as well as new derivatives of our 3rd generation AI technology.” Ambarella Has a Solid Quarter, Guided Weak Ambarella had a decent quarter but did not provide the market with a catalyst to justify the 15% run-up in share prices before the release. The company reported $62.14 million in revenue, which beat the consensus but only by 20 basis points and is down 31.2% compared to last year. The decline is due to cyclical headwinds that have reduced or pushed off demand in end markets, and there is no indication of a pick-up anytime soon. The company’s margin contracted compared to last year, but the details are not all bad. The gross margin declined by 70 basis points, and the operating loss widened, but GAAP and adjusted earnings were better than expected. An increase in R&D spending was offset by a decline in SG&A that left the adjusted EPS at -$0.15 compared to the -$0.21 forecast by the Marketbeat.com consensus figure. The bad news is that Q1's relative strength did not lead to positive guidance. The company expects revenue to run flattish compared to Q1 versus the consensus figure, which expected about 10% sequential growth, and the whisper figures suggested an NVIDIA-like blowout was possible. The Analysts Will Cap Price Action In 2023 The analysts rate Ambarella a Moderate Buy, but their activity will cap gains in 2023. The consensus price target is about 25% above the post-release price action but has been trending lower all year. The downtrend in the consensus target is not likely to end with the new guidance, but there is some good news too. The downtrend in the consensus target is due primarily to the top end of the range coming down; the most recent targets are reduced but to levels above the consensus. In this light, the analysts will likely cap gains in 2023 but will also support the market within its current trading range. The chart of Ambarella price action is worrisome. The pre and post-release action have the market set up to form an Abandoned Baby, a potentially bearish scenario. The Abandoned Baby may precede a downtrend but, in this case, represents a critical point of resistance. If the market can not move above the $80 level soon, the odds of range-bound trading in the 2nd half of the year will grow.
